Clinical trial: Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis (TAG-MS): A Phase 2, Randomized, Double-Blind, Parallel-Arm Study

https://clinicaltrials.gov/study/NCT07497399?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20315

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology